Tetrahedron Letters 55 (2014) 5191–5194
Contents lists available at ScienceDirect
Tetrahedron Letters journal homepage: www.elsevier.com/locate/tetlet
An enantioselective synthesis of a MEM-protected aetheramide A derivative Arun K. Ghosh ⇑, Kalapala Venkateswara Rao, Siddhartha Akasapu Department of Chemistry, and Department of Medicinal Chemistry, Purdue University, 560 Oval Drive, West Lafayette, IN 47907, United States
a r t i c l e
i n f o
Article history: Received 11 June 2014 Revised 17 July 2014 Accepted 21 July 2014 Available online 25 July 2014
a b s t r a c t Aetheramides A and B are very potent anti-HIV agents. An enantioselective synthesis of a MEM-protected aetheramide A derivative is described. The synthesis was accomplished in a convergent and stereoselective manner. The key reactions involved asymmetric dihydroxylation, asymmetric allylation, asymmetric syn-aldol reactions, and asymmetric hydrogenation. Ó 2014 Elsevier Ltd. All rights reserved.
Keywords: Anti-HIV Anticancer Natural product Asymmetric synthesis Aetheramides
Natural products are traditionally an excellent source of bioactive compounds including a variety of anti-HIV agents.1,2 While anti-HIV drugs developed through drug-design have greatly improved mortality and morbidity of HIV/AIDS patients, there has been a great deal of interest in natural product derived lead structures.3,4 Aetheramides A and B (compounds 1 and 2, Fig. 1) are unsaturated cyclic depsipeptides isolated from a novel myxobacterial genus Aetherobacter in 2012 by Müller and co-workers.5,6 Both aetheramides A and B contain a unique polyketide segment and a depsipeptide unit. Both these natural products exhibited potent anti-HIV activity with antiviral IC50 values around 15 nM, however, the mechanism of action has not yet been reported.6 Aetheramides also displayed cytostatic activity against human colon carcinoma cell lines with IC50 values of 110 nM. Furthermore, they have shown moderate antifungal activity against Candida albicans at loads of 20 lg/disk. Initial structures of aetheramides were elucidated by extensive NMR and mass spectral analysis, as well as chemical derivatizations and quantum mechanical calculations. The assignment of absolute stereochemistry of four of the six asymmetric centers has been reported. However, the stereochemistry of the C17 and C26 asymmetric centers has not yet been assigned. The potent anti-HIV activity of aetheramides and their unique structural features attracted our interest in their synthesis for structure–activity studies, investigation of mode of action, and
⇑ Corresponding author. E-mail address: [email protected] (A.K. Ghosh). http://dx.doi.org/10.1016/j.tetlet.2014.07.077 0040-4039/Ó 2014 Elsevier Ltd. All rights reserved.
HO MeO
O
O 17
O
Me
N NH
Me
1
O
O 26
OMe OH Me 1, Aetheramide A OMe HO O
H N O
OH
O
N
Me O
O Me
Me
OMe 2, Aetheramide B
Figure 1. Structures of aetheramides A and B.
design of novel structural variants. Herein, we report our preliminary synthetic efforts leading to an enantioselective synthesis of a protected aetheramide A derivative.
5192
A. K. Ghosh et al. / Tetrahedron Letters 55 (2014) 5191–5194
HO
CO2Et
MeO
O O
Cycloamidation
O OH
Me
N
O
1. TBSCl, Py
OMEM
2. MEMCl, i-Pr2NEt
7
NH
9
1. DIBAL-H 2. Swern Ox. (76% 3-steps) 3. Ph3P=CHCON(OMe)Me
(43% 2-steps)
O OMe OH Me 1, Aetheramide A
OTBS
O
O
10
1. DIBAL-H (55%) 2. Swern Ox. 3. (S)-BINAP, AgOTf, Allyltributylstannane
OTBS
OTBS
OMe 3
OMEM
OMEM
H OH
Me OMEM 11
OHC
Me
OEt
OTBS OMe
OMEM
OMEM 6
OH
OEt O
O OH
Me
5
OEt 7
Me
Scheme 1. Synthesis of homoallylic alcohol 11.
Asymmetric allylation
O OTBS
Me N OMe
(83% 2-steps)
Me
+
4
O
OTBS
2. Ph3P=C(Me)CO2Et
6
MeO NH OMe Me
CO2Et
OMEM
TBS
HO
MEMO
Me
1. DIBAL-H
Asymmetric syn-aldol
O
OTBS CO2Et
OH
resulting aldehyde afforded unsaturated ester 6 in 83% yield over two steps. Reaction of compound 6 with DIBAL-H followed by the Swern oxidation of the resulting alcohol provided the corresponding aldehyde in 88% yield over two steps. Asymmetric allylation of the resulting aldehyde with allyltributylstannane in the presence of a catalytic amount of (S)-BINAP (30 mol %) and AgOTf (30 mol %) afforded (S)-homoallylic alcohol 11 as the major diastereomer in 63% yield (87% BRSM).10
8
Figure 2. Retrosynthesis of aetheramide A.
X OTBS
As depicted in Figure 2, aetheramide A features a number of sensitive functionalities that are prone to elimination or epimerization. Particularly, the allylic ether at C26 and the methyl group at C17, both with unknown stereochemistry. As shown, our initial synthetic plan relied upon a cycloamidation reaction to construct the 22-membered macrocycle. Disconnection of the amino acid unit leads to polyketide unit 3, valine, and tyrosine derivative 4. The polyketide segment 3 can be assembled from a,b-unsaturated aldehyde 5 by an Evans aldol reaction. The C26-methyl ether stereochemistry is unassigned, however, we planned to synthesize the 26-(S)-isomer as a starting point using an asymmetric allylation reaction of the corresponding 6-derived aldehyde. This unsaturated ester can be constructed from optically active diol 7 which would be obtained by Sharpless asymmetric dihydroxylation of trans-ethyl cinnamate 8. The synthesis of homoallylic alcohol 11 is shown in Scheme 1. Optically active syn-diol 7 was prepared in multigram quantities by asymmetric dihydroxylation of ethyl cinnamate using a known procedure.7 Treatment of diol 7 with TBSCl in the presence of pyridine resulted in the selective protection of the benzylic alcohol in 50% yield.8 Reaction of the resulting alcohol with MEMCl in the presence of diisopropylethylamine (DIPEA) afforded MEM derivative 9 in 85% yield. Reduction of ester 9 with DIBAL-H provided the corresponding alcohol which was subjected to Swern oxidation to give an aldehyde. Wittig reaction of the aldehyde provided Weinreb amide 10 in 76% yield over 3 steps.9 Reaction of Weinreb amide 10 with DIBAL-H followed by the Wittig reaction of the
11
OMe
1. NaH, MeI OMEM
2. 9-BBN, THF (71% 2-steps)
12 X = OH
1. MsCl, Et3N 2. NaCN, DMSO (69% 2-steps)
13 X = CN
1. DIBAL-H (65% OHC 2. Ph3P=C(Me)- 2-steps) CHO O O
OTBS
O
OMe
N 14 Bn
Me
OMEM
Me
5 14, n-Bu2BOTf, (82%) Et N, -78 oC 3 O O
3
1. TBSOTf, 2,6-lutidine 2. aq. LiOH, 30% H2O2 (70% 2-steps)
O
OH Me
N Bn
OTBS OMe OMEM
Me
15 Scheme 2. Synthesis of polyketide segment 3.
5193
A. K. Ghosh et al. / Tetrahedron Letters 55 (2014) 5191–5194
Synthesis of polyketide segment 3 is outlined in Scheme 2. Reaction of compound 11 with NaH and MeI followed by hydroboration–oxidation provided alcohol 12 in 71% yield over two steps. Alcohol 12 was treated with methanesulfonyl chloride in the presence of Et3N to provide the corresponding mesylate. Reaction of the resulting mesylate with NaCN furnished nitrile 13 in 69% yield over two steps. Nitrile 13 was subjected to DIBAL-H reduction to provide the corresponding aldehyde. Wittig reaction of the resulting aldehyde afforded unsaturated aldehyde 5 in 65% yield over two steps. Aldol reaction of aldehyde 5 and chiral oxazolidinone 14 using Evans protocol afforded syn-aldol product 15 as a single isomer in 82% yield. The alcohol was protected as its TBS ether by reacting with TBSOTf in the presence of 2,6-lutidine. Hydrolysis of the oxazolidinone using LiOH–H2O2 provided acid 3 in 70% yield over two steps. Synthesis of tyrosine derivative 4 is shown in Scheme 3. Acylamido cinnamate ester 16 was prepared as described in the literature.11 Asymmetric hydrogenation of 16 was carried out with chiral rhodium catalyst using conditions developed by Boaz et al. to afford an optically active amino acid derivative.12 Removal of the benzyl protecting group by catalytic hydrogenation furnished amino acid 18 in 75% yield (over two steps) with 98% ee. Deprotection of the N-acetyl group of 18 by exposure to methanesulfonic acid followed by the reaction of the resulting amine with benzylchloroformate resulted in the Cbz-protection of amine as well as the formation of O-carbobenzyloxy derivative. Selective hydrolysis of the O-carbobenzyloxy group was achieved with K2CO3 in methanol to furnish Cbz-derivative 19 in 48% yield over three steps. Reaction of phenol 19 with MEM-Cl and DIPEA followed by Nmethylation13 and subsequent removal of the N-Cbz protecting group afforded amino acid derivative 4 in 51% yield over 3 steps. As shown in Scheme 4, coupling of acid 3 with amine 4 in the presence of BOPCl gave the corresponding amide 20 in 63% yield. The TBS ether of benzyl alcohol was selectively deprotected using TBAF–AcOH (1.6:1). The corresponding alcohol was obtained in 70% yield. Esterification of the resulting alcohol with F-Moc valine
MEMO MeO
O O
3
N
OTBS Me
MeO
Amine 4 BOPCl, DIPEA (63%)
OTBS OMe OMEM
Me
20 1. TBAF-AcOH (49% 2-steps) 2. Fmoc Val, EDC, DMAP, DIPEA MEMO MeO
O MeO
OTBS Me
N
O NH-Fmoc O
O OMe OMEM
Me
21 1. Me3SnOH 2. CH3CN, Et2 NH 3. BOPCl, 2,6-lutidine
(47% 3-steps) MEMO MeO
O O
OTBS Me
N NH
O
O OMe OMEM
Me
22 O
Bn
MeO
1. TBAF-AcOH (5:1) 53% 2. DMP (2 steps)
OH
1. (COD)2RhOTf H2, (S,R)-17
MeO
2. H2, 10% Pd-C 16
NHAc
MEMO
(75 % 2-steps)
CO2 Me
PPh2
CO2Me
18
NHAc
PPh2 N
MeO
O O
1. MeSO3H (48 % 2. CbzCl, Et3N 3-steps) 3. K CO , MeOH 2 3
Me
Me
N NH
O
OH
Me
O
O
MeO
Fe
OMe OMEM 23
19
(S, R)-17
Me
CO2Me Scheme 4. Synthesis of cycloamide 23.
NHCbz 1. MEMCl, DIPEA (51 % 2. MeI, Ag2O 3-steps) 3. H 2, 10% Pd(OH)2 OMEM MeO
4
CO2 Me Me
NH
Scheme 3. Synthesis of optically active amino acid 4.
using EDC, DIPEA, and DMAP afforded compound 21 in 70% (93% BRSM) yield. Hydrolysis of the methyl ester was accomplished using Me3SnOH in refluxing CH2Cl2 to provide the corresponding acid in 82% yield.14 Fmoc deprotection followed by cycloamidation using BOPCl15 afforded compound 22 in 57% yield over two steps. Treatment of compound 22 with TBAF–AcOH (5:1) followed by oxidation of the resulting alcohol using DMP provided b-keto cycloamide 23 in 53% yield over two steps.16 To complete the synthesis of aetheramide or its stereoisomer, we require to deprotect two MEM-protecting groups. Our subsequent attempts to remove
5194
A. K. Ghosh et al. / Tetrahedron Letters 55 (2014) 5191–5194
MEM groups from cycloamide 23 under acid-catalyzed conditions however, resulted in the elimination of the methyl ether followed by decomposition to a mixture of unidentified products. In conclusion, we have accomplished an enantioselective synthesis of MEM-protected aetheramide A derivative. The synthesis is convergent and features asymmetric dihydroxylation, asymmetric allylation, asymmetric syn-aldol reactions, and asymmetric hydrogenation as the key reactions. Our attempted removal of MEM protecting groups resulted in the decomposition of the product. Further investigation leading to the total synthesis of aetheramide A structure and structure–activity studies is in progress.
References and notes
Acknowledgment
10. 11.
Financial support by the National Institutes of Health (GM53386) is gratefully acknowledged.
12.
Supplementary data Supplementary data associated with this article can be found, in the online version, at http://dx.doi.org/10.1016/j.tetlet.2014. 07.077.
1. 2. 3. 4. 5. 6. 7. 8. 9.
13. 14. 15. 16.
Newman, D. J.; Cragg, G. M. J. Nat. Prod. 2012, 75, 311–335. Singh, I. P.; Bharate, S. B.; Bhutani, K. K. Curr. Sci. 2005, 89, 269–290. De Clercq, E. Int. J. Antimicrob. Agents 2009, 33, 307–320. Zhou, X.; Liu, J.; Yang, B.; Lin, X.; Yang, X.-W.; Liu, Y. Curr. Med. Chem. 2013, 20, 953–973. Garcia, R.; Gerth, K.; Stadler, M.; Dogma, I. J., Jr.; Müller, R. Mol. Phylogenet. Evol. 2010, 57, 878–887. Plaza, A.; Garcia, R.; Bifulco, G.; Martinez, J. P.; Hüttel, S.; Sasse, F.; Meyerhans, A.; Stadler, M.; Müller, R. Org. Lett. 2012, 14, 2854–2857. Kim, E. J.; An, K. M.; Ko, S. Y. Bull. Korean Chem. Soc. 2006, 27, 2019–2022. Yokomatsu, T.; Suemune, K.; Yamagishi, T.; Shibuya, S. Synlett 1995, 847–849. Evans, D. A.; Kaldor, S. W.; Jones, T. K.; Clardy, J.; Stout, T. J. J. Am. Chem. Soc. 1990, 112, 7001–7031. Georgy, M.; Lesot, P.; Campagne, J.-M. J. Org. Chem. 2007, 72, 3543–3549. Matta, M. S.; Kelley, A.; Rohde, M. F. U.S. Patent Application Publication U.S. 1973/3878043 A1. Boaz, N. W.; Large, S. E.; Ponasik, J. A., Jr.; Moore, M. K.; Barnette, T.; Nottingham, W. D. Org. Process Res. Dev. 2005, 9, 472–478. Kilitoglu, B.; Arndt, H. D. Synlett 2009, 720–723. Nicolaou, K. C.; Estrada, A. A.; Zak, M.; Lee, S. H.; Safina, B. S. Angew. Chem., Int. Ed. 2005, 44, 1378–1382. Liu, H.; Liu, Y.; Wang, Z.; Xing, X.; Maguire, A. R.; Luesch, H.; Zhang, H.; Xu, Z.; Ye, T. Chem. Eur. J. 2013, 19, 6774–6784. For more details, please see Supporting information section.
Contents lists available at ScienceDirect
Tetrahedron Letters journal homepage: www.elsevier.com/locate/tetlet
An enantioselective synthesis of a MEM-protected aetheramide A derivative Arun K. Ghosh ⇑, Kalapala Venkateswara Rao, Siddhartha Akasapu Department of Chemistry, and Department of Medicinal Chemistry, Purdue University, 560 Oval Drive, West Lafayette, IN 47907, United States
a r t i c l e
i n f o
Article history: Received 11 June 2014 Revised 17 July 2014 Accepted 21 July 2014 Available online 25 July 2014
a b s t r a c t Aetheramides A and B are very potent anti-HIV agents. An enantioselective synthesis of a MEM-protected aetheramide A derivative is described. The synthesis was accomplished in a convergent and stereoselective manner. The key reactions involved asymmetric dihydroxylation, asymmetric allylation, asymmetric syn-aldol reactions, and asymmetric hydrogenation. Ó 2014 Elsevier Ltd. All rights reserved.
Keywords: Anti-HIV Anticancer Natural product Asymmetric synthesis Aetheramides
Natural products are traditionally an excellent source of bioactive compounds including a variety of anti-HIV agents.1,2 While anti-HIV drugs developed through drug-design have greatly improved mortality and morbidity of HIV/AIDS patients, there has been a great deal of interest in natural product derived lead structures.3,4 Aetheramides A and B (compounds 1 and 2, Fig. 1) are unsaturated cyclic depsipeptides isolated from a novel myxobacterial genus Aetherobacter in 2012 by Müller and co-workers.5,6 Both aetheramides A and B contain a unique polyketide segment and a depsipeptide unit. Both these natural products exhibited potent anti-HIV activity with antiviral IC50 values around 15 nM, however, the mechanism of action has not yet been reported.6 Aetheramides also displayed cytostatic activity against human colon carcinoma cell lines with IC50 values of 110 nM. Furthermore, they have shown moderate antifungal activity against Candida albicans at loads of 20 lg/disk. Initial structures of aetheramides were elucidated by extensive NMR and mass spectral analysis, as well as chemical derivatizations and quantum mechanical calculations. The assignment of absolute stereochemistry of four of the six asymmetric centers has been reported. However, the stereochemistry of the C17 and C26 asymmetric centers has not yet been assigned. The potent anti-HIV activity of aetheramides and their unique structural features attracted our interest in their synthesis for structure–activity studies, investigation of mode of action, and
⇑ Corresponding author. E-mail address: [email protected] (A.K. Ghosh). http://dx.doi.org/10.1016/j.tetlet.2014.07.077 0040-4039/Ó 2014 Elsevier Ltd. All rights reserved.
HO MeO
O
O 17
O
Me
N NH
Me
1
O
O 26
OMe OH Me 1, Aetheramide A OMe HO O
H N O
OH
O
N
Me O
O Me
Me
OMe 2, Aetheramide B
Figure 1. Structures of aetheramides A and B.
design of novel structural variants. Herein, we report our preliminary synthetic efforts leading to an enantioselective synthesis of a protected aetheramide A derivative.
5192
A. K. Ghosh et al. / Tetrahedron Letters 55 (2014) 5191–5194
HO
CO2Et
MeO
O O
Cycloamidation
O OH
Me
N
O
1. TBSCl, Py
OMEM
2. MEMCl, i-Pr2NEt
7
NH
9
1. DIBAL-H 2. Swern Ox. (76% 3-steps) 3. Ph3P=CHCON(OMe)Me
(43% 2-steps)
O OMe OH Me 1, Aetheramide A
OTBS
O
O
10
1. DIBAL-H (55%) 2. Swern Ox. 3. (S)-BINAP, AgOTf, Allyltributylstannane
OTBS
OTBS
OMe 3
OMEM
OMEM
H OH
Me OMEM 11
OHC
Me
OEt
OTBS OMe
OMEM
OMEM 6
OH
OEt O
O OH
Me
5
OEt 7
Me
Scheme 1. Synthesis of homoallylic alcohol 11.
Asymmetric allylation
O OTBS
Me N OMe
(83% 2-steps)
Me
+
4
O
OTBS
2. Ph3P=C(Me)CO2Et
6
MeO NH OMe Me
CO2Et
OMEM
TBS
HO
MEMO
Me
1. DIBAL-H
Asymmetric syn-aldol
O
OTBS CO2Et
OH
resulting aldehyde afforded unsaturated ester 6 in 83% yield over two steps. Reaction of compound 6 with DIBAL-H followed by the Swern oxidation of the resulting alcohol provided the corresponding aldehyde in 88% yield over two steps. Asymmetric allylation of the resulting aldehyde with allyltributylstannane in the presence of a catalytic amount of (S)-BINAP (30 mol %) and AgOTf (30 mol %) afforded (S)-homoallylic alcohol 11 as the major diastereomer in 63% yield (87% BRSM).10
8
Figure 2. Retrosynthesis of aetheramide A.
X OTBS
As depicted in Figure 2, aetheramide A features a number of sensitive functionalities that are prone to elimination or epimerization. Particularly, the allylic ether at C26 and the methyl group at C17, both with unknown stereochemistry. As shown, our initial synthetic plan relied upon a cycloamidation reaction to construct the 22-membered macrocycle. Disconnection of the amino acid unit leads to polyketide unit 3, valine, and tyrosine derivative 4. The polyketide segment 3 can be assembled from a,b-unsaturated aldehyde 5 by an Evans aldol reaction. The C26-methyl ether stereochemistry is unassigned, however, we planned to synthesize the 26-(S)-isomer as a starting point using an asymmetric allylation reaction of the corresponding 6-derived aldehyde. This unsaturated ester can be constructed from optically active diol 7 which would be obtained by Sharpless asymmetric dihydroxylation of trans-ethyl cinnamate 8. The synthesis of homoallylic alcohol 11 is shown in Scheme 1. Optically active syn-diol 7 was prepared in multigram quantities by asymmetric dihydroxylation of ethyl cinnamate using a known procedure.7 Treatment of diol 7 with TBSCl in the presence of pyridine resulted in the selective protection of the benzylic alcohol in 50% yield.8 Reaction of the resulting alcohol with MEMCl in the presence of diisopropylethylamine (DIPEA) afforded MEM derivative 9 in 85% yield. Reduction of ester 9 with DIBAL-H provided the corresponding alcohol which was subjected to Swern oxidation to give an aldehyde. Wittig reaction of the aldehyde provided Weinreb amide 10 in 76% yield over 3 steps.9 Reaction of Weinreb amide 10 with DIBAL-H followed by the Wittig reaction of the
11
OMe
1. NaH, MeI OMEM
2. 9-BBN, THF (71% 2-steps)
12 X = OH
1. MsCl, Et3N 2. NaCN, DMSO (69% 2-steps)
13 X = CN
1. DIBAL-H (65% OHC 2. Ph3P=C(Me)- 2-steps) CHO O O
OTBS
O
OMe
N 14 Bn
Me
OMEM
Me
5 14, n-Bu2BOTf, (82%) Et N, -78 oC 3 O O
3
1. TBSOTf, 2,6-lutidine 2. aq. LiOH, 30% H2O2 (70% 2-steps)
O
OH Me
N Bn
OTBS OMe OMEM
Me
15 Scheme 2. Synthesis of polyketide segment 3.
5193
A. K. Ghosh et al. / Tetrahedron Letters 55 (2014) 5191–5194
Synthesis of polyketide segment 3 is outlined in Scheme 2. Reaction of compound 11 with NaH and MeI followed by hydroboration–oxidation provided alcohol 12 in 71% yield over two steps. Alcohol 12 was treated with methanesulfonyl chloride in the presence of Et3N to provide the corresponding mesylate. Reaction of the resulting mesylate with NaCN furnished nitrile 13 in 69% yield over two steps. Nitrile 13 was subjected to DIBAL-H reduction to provide the corresponding aldehyde. Wittig reaction of the resulting aldehyde afforded unsaturated aldehyde 5 in 65% yield over two steps. Aldol reaction of aldehyde 5 and chiral oxazolidinone 14 using Evans protocol afforded syn-aldol product 15 as a single isomer in 82% yield. The alcohol was protected as its TBS ether by reacting with TBSOTf in the presence of 2,6-lutidine. Hydrolysis of the oxazolidinone using LiOH–H2O2 provided acid 3 in 70% yield over two steps. Synthesis of tyrosine derivative 4 is shown in Scheme 3. Acylamido cinnamate ester 16 was prepared as described in the literature.11 Asymmetric hydrogenation of 16 was carried out with chiral rhodium catalyst using conditions developed by Boaz et al. to afford an optically active amino acid derivative.12 Removal of the benzyl protecting group by catalytic hydrogenation furnished amino acid 18 in 75% yield (over two steps) with 98% ee. Deprotection of the N-acetyl group of 18 by exposure to methanesulfonic acid followed by the reaction of the resulting amine with benzylchloroformate resulted in the Cbz-protection of amine as well as the formation of O-carbobenzyloxy derivative. Selective hydrolysis of the O-carbobenzyloxy group was achieved with K2CO3 in methanol to furnish Cbz-derivative 19 in 48% yield over three steps. Reaction of phenol 19 with MEM-Cl and DIPEA followed by Nmethylation13 and subsequent removal of the N-Cbz protecting group afforded amino acid derivative 4 in 51% yield over 3 steps. As shown in Scheme 4, coupling of acid 3 with amine 4 in the presence of BOPCl gave the corresponding amide 20 in 63% yield. The TBS ether of benzyl alcohol was selectively deprotected using TBAF–AcOH (1.6:1). The corresponding alcohol was obtained in 70% yield. Esterification of the resulting alcohol with F-Moc valine
MEMO MeO
O O
3
N
OTBS Me
MeO
Amine 4 BOPCl, DIPEA (63%)
OTBS OMe OMEM
Me
20 1. TBAF-AcOH (49% 2-steps) 2. Fmoc Val, EDC, DMAP, DIPEA MEMO MeO
O MeO
OTBS Me
N
O NH-Fmoc O
O OMe OMEM
Me
21 1. Me3SnOH 2. CH3CN, Et2 NH 3. BOPCl, 2,6-lutidine
(47% 3-steps) MEMO MeO
O O
OTBS Me
N NH
O
O OMe OMEM
Me
22 O
Bn
MeO
1. TBAF-AcOH (5:1) 53% 2. DMP (2 steps)
OH
1. (COD)2RhOTf H2, (S,R)-17
MeO
2. H2, 10% Pd-C 16
NHAc
MEMO
(75 % 2-steps)
CO2 Me
PPh2
CO2Me
18
NHAc
PPh2 N
MeO
O O
1. MeSO3H (48 % 2. CbzCl, Et3N 3-steps) 3. K CO , MeOH 2 3
Me
Me
N NH
O
OH
Me
O
O
MeO
Fe
OMe OMEM 23
19
(S, R)-17
Me
CO2Me Scheme 4. Synthesis of cycloamide 23.
NHCbz 1. MEMCl, DIPEA (51 % 2. MeI, Ag2O 3-steps) 3. H 2, 10% Pd(OH)2 OMEM MeO
4
CO2 Me Me
NH
Scheme 3. Synthesis of optically active amino acid 4.
using EDC, DIPEA, and DMAP afforded compound 21 in 70% (93% BRSM) yield. Hydrolysis of the methyl ester was accomplished using Me3SnOH in refluxing CH2Cl2 to provide the corresponding acid in 82% yield.14 Fmoc deprotection followed by cycloamidation using BOPCl15 afforded compound 22 in 57% yield over two steps. Treatment of compound 22 with TBAF–AcOH (5:1) followed by oxidation of the resulting alcohol using DMP provided b-keto cycloamide 23 in 53% yield over two steps.16 To complete the synthesis of aetheramide or its stereoisomer, we require to deprotect two MEM-protecting groups. Our subsequent attempts to remove
5194
A. K. Ghosh et al. / Tetrahedron Letters 55 (2014) 5191–5194
MEM groups from cycloamide 23 under acid-catalyzed conditions however, resulted in the elimination of the methyl ether followed by decomposition to a mixture of unidentified products. In conclusion, we have accomplished an enantioselective synthesis of MEM-protected aetheramide A derivative. The synthesis is convergent and features asymmetric dihydroxylation, asymmetric allylation, asymmetric syn-aldol reactions, and asymmetric hydrogenation as the key reactions. Our attempted removal of MEM protecting groups resulted in the decomposition of the product. Further investigation leading to the total synthesis of aetheramide A structure and structure–activity studies is in progress.
References and notes
Acknowledgment
10. 11.
Financial support by the National Institutes of Health (GM53386) is gratefully acknowledged.
12.
Supplementary data Supplementary data associated with this article can be found, in the online version, at http://dx.doi.org/10.1016/j.tetlet.2014. 07.077.
1. 2. 3. 4. 5. 6. 7. 8. 9.
13. 14. 15. 16.
Newman, D. J.; Cragg, G. M. J. Nat. Prod. 2012, 75, 311–335. Singh, I. P.; Bharate, S. B.; Bhutani, K. K. Curr. Sci. 2005, 89, 269–290. De Clercq, E. Int. J. Antimicrob. Agents 2009, 33, 307–320. Zhou, X.; Liu, J.; Yang, B.; Lin, X.; Yang, X.-W.; Liu, Y. Curr. Med. Chem. 2013, 20, 953–973. Garcia, R.; Gerth, K.; Stadler, M.; Dogma, I. J., Jr.; Müller, R. Mol. Phylogenet. Evol. 2010, 57, 878–887. Plaza, A.; Garcia, R.; Bifulco, G.; Martinez, J. P.; Hüttel, S.; Sasse, F.; Meyerhans, A.; Stadler, M.; Müller, R. Org. Lett. 2012, 14, 2854–2857. Kim, E. J.; An, K. M.; Ko, S. Y. Bull. Korean Chem. Soc. 2006, 27, 2019–2022. Yokomatsu, T.; Suemune, K.; Yamagishi, T.; Shibuya, S. Synlett 1995, 847–849. Evans, D. A.; Kaldor, S. W.; Jones, T. K.; Clardy, J.; Stout, T. J. J. Am. Chem. Soc. 1990, 112, 7001–7031. Georgy, M.; Lesot, P.; Campagne, J.-M. J. Org. Chem. 2007, 72, 3543–3549. Matta, M. S.; Kelley, A.; Rohde, M. F. U.S. Patent Application Publication U.S. 1973/3878043 A1. Boaz, N. W.; Large, S. E.; Ponasik, J. A., Jr.; Moore, M. K.; Barnette, T.; Nottingham, W. D. Org. Process Res. Dev. 2005, 9, 472–478. Kilitoglu, B.; Arndt, H. D. Synlett 2009, 720–723. Nicolaou, K. C.; Estrada, A. A.; Zak, M.; Lee, S. H.; Safina, B. S. Angew. Chem., Int. Ed. 2005, 44, 1378–1382. Liu, H.; Liu, Y.; Wang, Z.; Xing, X.; Maguire, A. R.; Luesch, H.; Zhang, H.; Xu, Z.; Ye, T. Chem. Eur. J. 2013, 19, 6774–6784. For more details, please see Supporting information section.
![[Enantioselective biotransformation of a new theophylline derivative].](/assets/img/hold.png)
